Strattera Withdrawal and Tapering Help
Strattera alters Norepinephrine which plays a role in memory, attention, stress reactions, theregulation of emotions and energy levels.
Point of Return Can Help You
The Point of Return Program is an in-home tapering program that allows you to gradually taper the amount of Strattera while also implementing the use of all-natural, calming nutraceuticals to help ease withdrawal symptoms. We eliminate Interaction items to help make Strattera withdrawal more comfortable. Our physician recommended schedules allow your doctor to taper you off Strattera correctly. Strattera can be dangerous to abruptly or rapidly stop and our program is a proven, viable, low-cost option to continue living your life while tapering.* Read program FAQs.
Key Components of our In-Home Program
- Skilled Experts in Prescription Drugs guiding you throughout the process
- Assessment at the onset to determine a gameplan
- *Nutraceuticals specially formulated to help ease symptoms, these are utilized throughout the whole process
- Unlike herbs and many vitamins, our nutraceuticals will not interact medications
- 24/7 discussion board with encouraging members and knowledgeable mentors
- Recommendations for addressing symptoms
- Experienced team of committed experts with 15 years experience
Break Free Today
At Point of Return, a 501(c)3 nonprofit, we have spent the last 15 years helping people come off prescription medications correctly. With customized taper rates and all natural nutraceuticals, our program allows you to taper off Strattera, once and for all, from the comfort of your home. Read program FAQs
Strattera is a Selective Norepinephrine Reuptake Inhibitor approved for the treatment of attention-deficit hyperactivity disorder (ADHD). In the clinical trials Strattera failed as an antidepressant, and instead was marketed as a non-stimulant treatment for ADHD. Although Strattera was in the same class as Effexor, which is not recommended for children because of the risk of suicide, Strattera became the fastest growing ADHD drug and captured a 16% of the market share within 9 months. It is estimated that nearly one million children were prescribed Strattera in 2003. In September 2005 the FDA found that Strattera may prompt suicidal thoughts in children and the black box warning was required.
*While great care has been taken in organizing and presenting the material throughout this website, please note that it is provided for informational purposes only and should not be taken as Medical Advice.
*The statements/info on this website have not been evaluated by the Food and Drug Administration (FDA). The products and labels mentioned / sold are not intended to diagnose, treat, cure, or prevent any disease or illness.
* Testimonial results may vary person to person.
*The program outlined in Point of Return is not meant to substitute your doctor, instead it is to be utilized With Your physician to help you with your drug withdrawal process and with his or her consent and support throughout.
*This program is not meant to cure or prevent any disease or illness.
*Because prescription medications can cause severe withdrawal reactions, do not stop taking any medication without first consulting your physician. The decision to taper any medication should be discussed with your doctor and done with their consent and support throughout the process. More...